<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Soma A. Mohammed</style></author><author><style face="normal" font="default" size="100%">Entedhar R. Sarhat</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Evaluation of Serum Eta Protein, Sclerostin, and Calcitonin Level in Arthritis Patients on Vitamin D Therapy</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Arthritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Calcitonin</style></keyword><keyword><style  face="normal" font="default" size="100%">ETA protein</style></keyword><keyword><style  face="normal" font="default" size="100%">Sclerostin</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitamin D</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">426-430</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Arthritis is an inflammatory condition affecting the diarthrodial joints. A joint's bone, cartilage, and structural design all preserve its integrity, and arthritis alters that integrity, resulting in joint activity loss and discomfort. The primary symptom of arthritis is joint pain, although other symptoms include stiffness, inflammation, and impaired joint motor function. &lt;strong&gt;Methods:&lt;/strong&gt; The cross-sectional study comprised 90 subjects: 70 arthritis sufferers and 20 controls, ages 25-60, both sexes. From September 2023 to March 2024, patients were referred to Kirkuk city in Azadi hospital and Kirkuk general hospital. The research participants were placed into three groups: Group 1 for arthritic patients without Vit D (35). Patients with arthritis who received vitamin D for at least two months (G2), n (35), were the second group. The third group comprised healthy individuals without arthritis n (20). &lt;strong&gt;Result:&lt;/strong&gt; Significant (P&amp;lt;0.05) increase in ETA protein levels in G1 and G2 compared to G3. G1 had ETA protein levels of 28.05±5.34 ng/L, G2 had 24.10±3.67 ng/L, and G3 had 8.92±2.80 ng/L. Sclerostin levels peaked in G1 (0.4273±0.3023 pg/mL) and declined in G2 (P&amp;lt;0.05) compared to G3. Calcitonin levels were higher in G1 (34.72±4.72 pg/mL) and G2 (27.06±5.85 pg/mL) than G3 (14.71±3.71 pg/mL) at (P&amp;lt;0.05). &lt;strong&gt;Conclusion:&lt;/strong&gt; The study found a rise in ETA protein and calcitonin levels in arthritic patients before and after therapy with vitamin D, which was not influenced by vitamin supplementation. Sclerostin levels increase in arthritic patients and decrease following therapy with vitamin D.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">426</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Soma A. Mohammed&lt;sup&gt;1&lt;/sup&gt;, Entedhar R. Sarhat&lt;sup&gt;2*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;College of Medicine, Tikrit University, Tikrit, IRAQ.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;College of Dentistry, Tikrit University, Tikrit, IRAQ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mardin M. Obied</style></author><author><style face="normal" font="default" size="100%">Entedhar R. Sarhat</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The Role of Vitamin D-Binding Protein, and Procalcitonin in Patients with Arthritis on Vitamin D</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Arthritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Procalcitonin</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitamin D</style></keyword><keyword><style  face="normal" font="default" size="100%">Vitamin D-binding Protein</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">431-435</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Arthritis is a term often used to mean any disorder that affects joints. Symptoms generally include joint pain and stiffness. Other symptoms may include redness, warmth, swelling, and decreased range of motion of the affected joints. In some types of arthritis, other organs are also affected. &lt;strong&gt;Aim:&lt;/strong&gt; This study aimed to identify the impact of vitamin D therapy on serum level of vitamin D-binding protein and procalcitonin in Patients with arthritis.&lt;strong&gt; Methods: &lt;/strong&gt;This cross-sectional study, was conducted in Kirkuk city between January 1st and March 1st, 2024. A total of 180 subjects were included, categorized into three groups: arthritis patients not receiving vitamin D (Group 1), arthritis patients receiving vitamin D for at least 2 months (Group 2), and a control group comprising 40 healthy subjects. Blood samples were collected from participants, processed, and stored for subsequent analysis. Various biomarkers, including vitamin D-binding protein and procalcitonin, were determined using ELISA kits. &lt;strong&gt;Results:&lt;/strong&gt; The study revealed a higher prevalence of females among arthritis patients (54.29%), with most affected individuals aged above 60 years. Urban residency was predominant among arthritis patients (75.71%). The majority of RA patients had been affected for 6-10 years (40%). Comparative analysis demonstrated significantly higher procalcitonin levels in RA patients without vitamin D supplementation (112.4±24.3 ng/ ml) compared to those with supplementation (48.33±10.73 ng/ml) and healthy controls (9.68±5.49 ng/ ml). Furthermore, vitamin D binding protein levels were significantly lower in arthritis patients without supplementation (1.26±0.12 ng/ml) compared to those with supplementation (0.75±0.15 ng/ml) and healthy controls (0.23±0.14 ng/ml).&lt;strong&gt; Conclusion: &lt;/strong&gt;These findings underscore the potential role of vitamin D supplementation in modulating inflammatory markers and enhancing vitamin D binding protein levels in arthritis patients, suggesting its therapeutic implications in disease management.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">431</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Mardin M. Obied&lt;sup&gt;1&lt;/sup&gt;, Entedhar R. Sarhat&lt;sup&gt;2,*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;M1Kirkuk Health Directorate, Tikrit, IRAQ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;College of Dentistry, Tikrit University, Tikrit, IRAQ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">P Praveen Kumar</style></author><author><style face="normal" font="default" size="100%">K Prabhu</style></author><author><style face="normal" font="default" size="100%">Mudiganti Ram Krishna Rao</style></author><author><style face="normal" font="default" size="100%">Mallika Jain</style></author><author><style face="normal" font="default" size="100%">K Kalaivani</style></author><author><style face="normal" font="default" size="100%">Shruthi Dinakar</style></author><author><style face="normal" font="default" size="100%">Sampad Shil</style></author><author><style face="normal" font="default" size="100%">N Vijayalakshmi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-arthritic Property of Sahacharadi Kashayam Against Freund's Complete</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-arthritic activity</style></keyword><keyword><style  face="normal" font="default" size="100%">Arthritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Biomarkers</style></keyword><keyword><style  face="normal" font="default" size="100%">Sahacharadi Kashayam</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">May2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">459-464</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The available modern molecular drugs for the therapy of Rheumatoid arthritis are beset with several side effects and alternative drugs are urgently needed. The present investigation was performed to evaluate the anti-arthritic activity of Sahacharadi Kashayam (SK), an Ayurvedic formulation, against Freund's complete adjuvant (CFA) - induced arthritis in rats. &lt;strong&gt;Methods: &lt;/strong&gt;In this experimental trial, SK was administered at doses of 0.5, 1.0 and 1.5 ml/kg body weight orally to adjuvant (CFA) induced arthritic rats. The anti-arthritic activity was evaluated by using paw volume, haematological parameters and arthritic biomarkers. The efficacy of the Kashayam was compared with the standard Leflunomide (10 mg/kg) drug. &lt;strong&gt;Results: &lt;/strong&gt;Significant reduction in paw volume and thickness by SK (0.5 ml dose) has been found and there was considerably improvement in haematological parameters and arthritic markers in CFA rats till 14 days. After 14&lt;sup&gt;th&lt;/sup&gt; day SK treatment with doses (1.0 and 1.5ml), however, reoccurrence of inflammation and pathological changes were observed in rats.&lt;strong&gt; Conclusion: &lt;/strong&gt;The study clearly indicated the anti-arthritic role of SK. Future studies, however, are warranted to provide a new approach in relation to the therapeutic dose and treatment period of SK which may eventually lead to the development of a new category of the anti-arthritic agent.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">459</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;P Praveen Kumar&lt;sup&gt;1&lt;/sup&gt;, K Prabhu&lt;sup&gt;2&lt;/sup&gt;, Mudiganti Ram Krishna Rao&lt;sup&gt;3,&lt;/sup&gt;*, Mallika Jain&lt;sup&gt;4&lt;/sup&gt;, K Kalaivani&lt;sup&gt;5&lt;/sup&gt;, Shruthi Dinakar&lt;sup&gt;6&lt;/sup&gt;, Sampad Shil&lt;sup&gt;7&lt;/sup&gt;, N. Vijayalakshmi&lt;sup&gt;7&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Research Scholar, Sree Balaji Medical College and Hospital, Bharath University, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Associate Professor, Department of Anatomy, Sree Balaji Medical College and Hospital, Bharath University, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Professor, Department of Industrial Biotechnology, Bharath Institute of Higher Education and Research, Chennai, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Scientist, Bright Care Research Private Ltd, Chennai, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Professor, Indira Priyadarshini Dental College, Chennai, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Ayurvedic Practitioner, Kottakkal Arya Vaidhya Sala, Chennai, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Student, Department of Industrial Biotechnology, Bharath Institute of Higher Education and Research, Chennai, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nkiru Nwamaka Ezeani</style></author><author><style face="normal" font="default" size="100%">Udu Ama Ibiam</style></author><author><style face="normal" font="default" size="100%">Obasi Uche Orji</style></author><author><style face="normal" font="default" size="100%">Ikechuku Okorie Igwenyi</style></author><author><style face="normal" font="default" size="100%">Chinyere Aloke</style></author><author><style face="normal" font="default" size="100%">Esther Alum</style></author><author><style face="normal" font="default" size="100%">Partrick Mmaduabuchi Aja</style></author><author><style face="normal" font="default" size="100%">Okechukwu Paul Chima Ugwu</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effects of Aqueous and Ethanol Root Extracts of Olax subscopioidea on Inflammatory Parameters in Complete Freund’s Adjuvant-Collagen Type II Induced Arthritic Albino Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adjuvant</style></keyword><keyword><style  face="normal" font="default" size="100%">Arthritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Indomethacine</style></keyword><keyword><style  face="normal" font="default" size="100%">Plant extracts</style></keyword><keyword><style  face="normal" font="default" size="100%">Rats</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">16-25</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Aim/Background:&lt;/strong&gt; Rural and Urban dwellers in Nigeria claim to treat their arthritis with &lt;em&gt;Olax subscorpioidea&lt;/em&gt; root extracts. One of the reasons they chose this treatment is that it is effective and cost less than orthodox drugs with their accompanying side effects. Hence the aim of this study is to investigate the anti-arthritis effects of &lt;em&gt;Olax subscorpioidea &lt;/em&gt;Afzel ethanol and aqueous root extracts on chicken type II-Complete Freund’s adjuvant (CFA) induced arthritis rat model. &lt;strong&gt;Materials and Method:&lt;/strong&gt; The anti-arthritic potential of ethanol and aqueous root extracts of &lt;em&gt;Olax subscorpioidea&lt;/em&gt; was evaluated using the chicken type II-Complete Freund’s adjuvant model in 135 female wistar albino rats. The rats were treated with aqueous and ethanol root extracts of &lt;em&gt;Olax subscorpioidea&lt;/em&gt; at varying doses and standard indomethacine drug. &lt;strong&gt;Results:&lt;/strong&gt; The ethanol and aqueous root extracts of &lt;em&gt;Olax subscorpioidea &lt;/em&gt;showed significant anti-arthritic activity that was statistically similar to that of indomethacine. Our results suggest that the alcoholic extract of &lt;em&gt;Olax subscorpioidea &lt;/em&gt;showed significant (&lt;em&gt;P&lt;/em&gt;&amp;lt;0.05) anti-arthritic potential.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">16</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Nkiru Nwamaka Ezeani&lt;sup&gt;*&lt;/sup&gt;, Udu Ama Ibiam, Obasi Uche Orji, Ikechuku Okorie Igwenyi, Chinyere Aloke, Esther Alum, Partrick Mmaduabuchi Aja, Okechukwu Paul Chima Ugwu &lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Department of Biochemistry, Ebonyi State University, Abakaliki, NIGERIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dwaipayan Sinha</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A Review on Ethnobotanical, Phytochemical and Pharmacological Profile of Pinus wallichiana A.B. Jacks</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antioxidant</style></keyword><keyword><style  face="normal" font="default" size="100%">Arthritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Conifer</style></keyword><keyword><style  face="normal" font="default" size="100%">Flavonoids</style></keyword><keyword><style  face="normal" font="default" size="100%">Himalaya</style></keyword><keyword><style  face="normal" font="default" size="100%">Terpenoids</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">July 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">624-631</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; &lt;em&gt;Pinus wallichiana &lt;/em&gt;A.B. Jacks. or the blue pine is one of the important conifer that grows all along the Himalayan range from Afghanistan in the west to Myanmar and China in the east covering the Himalayan regions of Pakistan, Nepal and India. It is found in the upper region of the mountains and often remains associated with other gymnosperms. The plant is of immense ethnobotanical relevance and finds extensive use among the people inhabiting the mountainous region. They are primarily valued for its timber and used for construction and infrastructural purposes. Medicinally the plant is very much important. Throughout the Himalayan region the plant is used for the cure of a number of diseases including treatment of fever, cough and cold, bone fracture, healing of injury and wounds, rheumatic pain, arthritis, inflammations etc. The plant is rich in terpenoids and flavonoids all of which possess strong antioxidant properties. &lt;strong&gt;Methods: &lt;/strong&gt;Extensive literature survey was made in the internet with pubmed, google scholar forming the search platform to illustrate the traditional usage of the plant among inhabitants of various regions of Himalayas. Informations of traditional usage, chemical constituents and selected pharmacological activities of the plant were pooled from available research papers to frame the review. &lt;strong&gt;Results and Outcome:&lt;/strong&gt; In this review, an attempt has been made to compile the ethnobotanical usage of &lt;em&gt;Pinus wallichiana&lt;/em&gt;, its phytochemistry and pharmacological activity highlighting its potentiality as a cheap and affordable source of drugs for the benefit of population of Indian subcontinent and adjoining areas.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">624</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Dwaipayan Sinha* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Department of Botany, Government General Degree College, Mohanpur, Paschim Medinipur West Bengal-721436, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>